Literature DB >> 17493654

High levels of subgenomic HCV plasma RNA in immunosilent infections.

Flavien Bernardin1, Susan L Stramer, Barbara Rehermann, Kimberly Page-Shafer, Stewart Cooper, David R Bangsberg, Judith Hahn, Leslie Tobler, Michael Busch, Eric Delwart.   

Abstract

A genetic analysis of hepatitis C virus (HCV) in rare blood donors who remained HCV seronegative despite long-term high-level viremia revealed the chronic presence of HCV genomes with large in frame deletions in their structural genes. Full-length HCV genomes were only detected as minority variants. In one immunodeficiency virus (HIV) co-infected donor the truncated HCV genome transiently decreased in frequency concomitant with delayed seroconversion and re-emerged following partial seroreversion. The long-term production of heavily truncated HCV genomes in vivo suggests that these viruses retained the necessary elements for RNA replication while the deleted structural functions necessary for their spread in vivo was provided in trans by wild-type helper virus in co-infected cells. The absence of immunological pressure and a high viral load may therefore promote the emergence of truncated HCV subgenomic replicons in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17493654      PMCID: PMC2001282          DOI: 10.1016/j.virol.2007.04.003

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  72 in total

1.  Prolonged antibody-negative HCV viremia in a US blood donor with apparent HCV transmission to a recipient.

Authors:  B G Peoples; S B Preston; J L Tzeng; S L Stramer; L Gifford; M E Wissel
Journal:  Transfusion       Date:  2000-10       Impact factor: 3.157

2.  Complementation analysis of the flavivirus Kunjin NS3 and NS5 proteins defines the minimal regions essential for formation of a replication complex and shows a requirement of NS3 in cis for virus assembly.

Authors:  Wen Jun Liu; Petra L Sedlak; Natasha Kondratieva; Alexander A Khromykh
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 3.  Natural history of hepatitis C.

Authors:  A Alberti; L Chemello; L Benvegnù
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

4.  Lack of seroconversion in a health care worker after polymerase chain reaction-documented acute hepatitis C resulting from a needlestick injury.

Authors:  P Morand; N Dutertre; H Minazzi; J Burnichon; M Pernollet; M Baud; J P Zarski; J M Seigneurin
Journal:  Clin Infect Dis       Date:  2001-07-26       Impact factor: 9.079

5.  Establishment of persistent infection with non-cytopathic bovine viral diarrhoea virus in cattle is associated with a failure to induce type I interferon.

Authors:  B Charleston; M D Fray; S Baigent; B V Carr; W I Morrison
Journal:  J Gen Virol       Date:  2001-08       Impact factor: 3.891

Review 6.  Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients.

Authors:  M P Busch
Journal:  Transfus Clin Biol       Date:  2001-06       Impact factor: 1.406

7.  Genetic analysis of the pestivirus nonstructural coding region: defects in the NS5A unit can be complemented in trans.

Authors:  C W Grassmann; O Isken; N Tautz; S E Behrens
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

8.  Quality of life in long-term survivors after liver transplantation: impact of recurrent viral hepatitis C virus hepatitis.

Authors:  D L Paterson; T Gayowski; C F Wannstedt; M M Wagener; I R Marino; H Vargas; T Laskus; J Rakela; N Singh
Journal:  Clin Transplant       Date:  2000-02       Impact factor: 2.863

9.  A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg.

Authors:  Olga Kalinina; Helene Norder; Sergey Mukomolov; Lars O Magnius
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

10.  Time-related changes in full-length hepatitis C virus sequences and hepatitis activity.

Authors:  K Nagayama; M Kurosaki; N Enomoto; S Y Maekawa; Y Miyasaka; J Tazawa; N Izumi; F Marumo; C Sato
Journal:  Virology       Date:  1999-10-10       Impact factor: 3.616

View more
  12 in total

Review 1.  Persistent RNA virus infections: do PAMPS drive chronic disease?

Authors:  Mary K McCarthy; Thomas E Morrison
Journal:  Curr Opin Virol       Date:  2017-02-17       Impact factor: 7.090

2.  Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.

Authors:  Kimberly Page; Judith A Hahn; Jennifer Evans; Stephen Shiboski; Paula Lum; Eric Delwart; Leslie Tobler; William Andrews; Lia Avanesyan; Stewart Cooper; Michael P Busch
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

3.  Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates.

Authors:  Kimberly Page-Shafer; Brandee L Pappalardo; Leslie H Tobler; Bruce H Phelps; Brian R Edlin; Andrew R Moss; Teresa L Wright; David J Wright; Thomas R O'Brien; Sally Caglioti; Michael P Busch
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948

4.  Dynamics of defective hepatitis C virus clones in reinfected liver grafts in liver transplant recipients: ultradeep sequencing analysis.

Authors:  Shigeru Ohtsuru; Yoshihide Ueda; Hiroyuki Marusawa; Tadashi Inuzuka; Norihiro Nishijima; Akihiro Nasu; Kazuharu Shimizu; Kaoru Koike; Shinji Uemoto; Tsutomu Chiba
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

5.  Naturally occurring hepatitis C virus subgenomic deletion mutants replicate efficiently in Huh-7 cells and are trans-packaged in vitro to generate infectious defective particles.

Authors:  Laura Pacini; Rita Graziani; Linda Bartholomew; Raffaele De Francesco; Giacomo Paonessa
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

6.  Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users.

Authors:  M Zeremski; M A Shu; Q Brown; Y Wu; D C Des Jarlais; M P Busch; A H Talal; B R Edlin
Journal:  J Viral Hepat       Date:  2008-07-17       Impact factor: 3.728

7.  Hepatitis C virus RNA replication depends on specific cis- and trans-acting activities of viral nonstructural proteins.

Authors:  Teymur Kazakov; Feng Yang; Harish N Ramanathan; Andrew Kohlway; Michael S Diamond; Brett D Lindenbach
Journal:  PLoS Pathog       Date:  2015-04-13       Impact factor: 6.823

8.  The First Complete Genome Sequences of Hepatitis C Virus Subtype 2b from Latin America: Molecular Characterization and Phylogeographic Analysis.

Authors:  Natália Spitz; José J Barros; Kycia M do Ó; Carlos E Brandão-Mello; Natalia M Araujo
Journal:  Viruses       Date:  2019-10-31       Impact factor: 5.048

9.  Hepatitis C Virus Deletion Mutants Are Found in Individuals Chronically Infected with Genotype 1 Hepatitis C Virus in Association with Age, High Viral Load and Liver Inflammatory Activity.

Authors:  Cristina Cheroni; Lorena Donnici; Alessio Aghemo; Francesca Balistreri; Annalisa Bianco; Valeria Zanoni; Massimiliano Pagani; Roberta Soffredini; Roberta D'Ambrosio; Maria Grazia Rumi; Massimo Colombo; Sergio Abrignani; Petra Neddermann; Raffaele De Francesco
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

10.  A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs.

Authors:  Vivian D Hope; Ross J Harris; Peter Vickerman; Lucy Platt; Justin Shute; Katelyn J Cullen; Samreen Ijaz; Sema Mandal; Fortune Ncube; Monica Desai; John V Parry
Journal:  Euro Surveill       Date:  2018-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.